<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <bill>
    <billNumber>1427</billNumber>
    <createDate>2021-04-29T04:57:18Z</createDate>
    <updateDate>2022-03-04T01:12:11Z</updateDate>
    <originChamber>Senate</originChamber>
    <billType>S</billType>
    <introducedDate>2021-04-28</introducedDate>
    <congress>117</congress>
    <recordedVotes/>
    <committees>
      <billCommittees>
        <item>
          <systemCode>ssfi00</systemCode>
          <name>Finance Committee</name>
          <chamber>Senate</chamber>
          <type>Standing</type>
          <subcommittees/>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2021-04-28T21:08:31Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports/>
    <relatedBills>
      <item>
        <latestTitle>Increasing Access to Biosimilars Act of 2021</latestTitle>
        <congress>117</congress>
        <number>2869</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2021-04-29</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2021-04-28</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <links/>
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2021-04-28</actionDate>
        <links/>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees/>
      </item>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>C001056</bioguideId>
        <fullName>Sen. Cornyn, John [R-TX]</fullName>
        <firstName>John</firstName>
        <middleName/>
        <lastName>Cornyn</lastName>
        <party>R</party>
        <state>TX</state>
        <identifiers>
          <lisID>1692</lisID>
          <bioguideId>C001056</bioguideId>
          <gpoId>8295</gpoId>
        </identifiers>
        <byRequestType/>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B001267</bioguideId>
        <fullName>Sen. Bennet, Michael F. [D-CO]</fullName>
        <firstName>Michael</firstName>
        <middleName/>
        <lastName>Bennet</lastName>
        <party>D</party>
        <state>CO</state>
        <identifiers>
          <lisID>1965</lisID>
          <bioguideId>B001267</bioguideId>
          <gpoId>8302</gpoId>
        </identifiers>
        <sponsorshipDate>2021-04-28</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate/>
      </item>
    </cosponsors>
    <cboCostEstimates/>
    <laws/>
    <notes/>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health care costs and insurance</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Medicare</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2021-04-28</actionDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <lastSummaryUpdateDate>2021-06-15T16:16:25Z</lastSummaryUpdateDate>
          <text>
            <![CDATA[ <p><b>Increasing Access to Biosimilars Act of </b><b>2021</b></p> <p>This bill requires the Centers for Medicare &amp; Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead. </p>]]>
          </text>
          <updateDate>2021-04-28T04:00:00Z</updateDate>
          <name>Introduced in Senate</name>
        </item>
      </billSummaries>
    </summaries>
    <title>Increasing Access to Biosimilars Act of 2021</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType/>
        <title>Increasing Access to Biosimilars Act of 2021</title>
        <chamberCode/>
        <chamberName/>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <parentTitleType>Short Title</parentTitleType>
        <title>Increasing Access to Biosimilars Act of 2021</title>
        <chamberCode/>
        <chamberName/>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType/>
        <title>A bill to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.</title>
        <chamberCode/>
        <chamberName/>
      </item>
    </titles>
    <amendments/>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2021-04-28T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117s1427is/xml/BILLS-117s1427is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2021-04-28</actionDate>
      <text>Read twice and referred to the Committee on Finance.</text>
      <links/>
    </latestAction>
    <calendarNumbers/>
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
